13326. Adulteration and misbranding of codeine phosphate tablets, codeine
sulphate tablets, morphine  sulphate  tablets,  and  strychuine  sul- 
phate tablets.    U. S. v. the Tilden Co.    Plea of guilty.     Fine, $500.
(F. & D. No. 19008.    I. S. Nos. 5323-v, 7352-v, 7356-v, 18106-v, 18107-v.)
On January 7, 1925, the United States attorney for the Eastern District of 
Missouri, acting upon a report by the Secretary of Agriculture, filed in the 
District Court of the United States for said district an information against 
the Tilden Co., a corporation, trading at St. Louis, Mo., alleging shipment by 
said company, in violation of the food and drugs act, on or about October 23, 
3923. from the State of Missouri into the State of Kansas, of a quantity of 
codeine phosphate tablets, on or about November 15. 1923, from the State of 
Missouri into the State of Louisiana, of quantities of codeine sulphate tablets 
and of strychnine stilphate tablets, and on or about December 4, 1923, from 
the State of Missouri into the State of Ohio, of quantities of morphine sulphate 
tablets and codeine sulphate tablets, respectively, which were adulterated and 
misbranded. The respective articles were labeled in part: " H. T. Codeine 
Phosphate 1-2 Gr." ; " Hypodermic Tablets Codeine Sulphate 1-2 Gr." ; " Hypo- 
dermic Tablets Morphine Sulphate 1-2 Gr."; or " Tablet Triturates Strychnine 
Sulphate 3-30 Gr.," as the case might be, and " Manufactured by The Tilden 
Co. Pharmacists-Chemists New Lebanon, N. Y. St. Louis, Mo."
Analyses of samples of the articles by the Bureau of Chemistry of this de- 
partment showed that: The two consignments of codeine sulphate tablets 
contained averages of not more than 0.396 grain and 0.401 grain of codeine sul- 
phate each; the morphine sulphate tablets examined contained an average 
of not more than 0.356 grain of morphine sulphate each, the strychnine sul- 
phate tablets examined contained an average of not more than 0.0291 grain 
of strychnine sulphate each, and the alleged codeine phosphate tablets ex- 
amined contained no codeine phosphate but did contain an average of not 
more than 0.39 grain of codeine sulphate each.
Adulteration of the articles was alleged in the information for the reason 
that their strength and purity fell below the professed standard and quality 
under which they were sold.
Misbranding was alleged for the reason that the respective statements, to 
wit, "H. T. Codeine Phosphate 1-2 Gr.," "100 Hypodermic Tablets Codeine 
Sulphate 1-2 Gr.," " 100 Hypodermic Tablets Morphine Sulphate 1-2 Gr.," " 100 
Tablet Triturates Strychnine Sulphate 1-30 Gr.," borne on the labels of the 
bottles containing the articles, were false and misleading, since the said state-
merits represented that each of the said tablets contained the amount of the 
article declared on the label, whereas the alleged codeine phosphate tablets 
contained no codeine phosphate but did contain codeine sulphate, and the 
remaining tablets contained less of the respective products than declared on the 
labels. Misbranding was alleged with respect to the alleged codeine phosphate 
tablets for the further reason that it was an imitation of and was offered 
for sale under the name of another article, codeine phosphate tablets.
On March 3, 1925, a plea of guilty to the information was entered on behalf 
of the defendant company, and the court imposed a fine of $500.
E. W. DUNLAP, Acting Secretary of Agriculture.